AMG131

产品说明书

Print
Chemical Structure| 315224-26-1 同义名 : INT131
CAS号 : 315224-26-1
货号 : A730462
分子式 : C21H12Cl4N2O3S
纯度 : 95%
分子量 : 514.21
MDL号 : MFCD13152369
存储条件:

Pure form Sealed in dry, 2-8°C

In solvent -20°C:3-6个月-80°C:12个月

溶解度 : -
动物实验配方:
生物活性
描述 AMG-131 is a hypoglycemic agent. It is a potent PPARγ partial agonist that displays robust glucose-lowering activity in rodent models of diabetes while exhibiting a reduced side-effects profile compared to marketed TZDs.
临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点
NCT00952445 Diabetes Mellitus, Type II Phase 2 Completed - United States, California ... 展开 >> Whittier Diabetes Institute La Jolla, California, United States Charles R. Drew University Los Angeles, California, United States National Research Institute Los Angeles, California, United States Lovelace Research Institute Santa Ana, California, United States United States, Florida University of Miami Miami, Florida, United States United States, Indiana GFI Research Center Evansville, Indiana, United States United States, Massachusetts Joslin Diabetes Center Boston, Massachusetts, United States United States, Minnesota Radiant Research Edina, Minnesota, United States United States, Missouri Radiant Research St. Louis, Missouri, United States St Louis Center for Clinical Research St. Louis, Missouri, United States United States, New York Kaleida Health Diabetes Center Buffalo, New York, United States Rochester Clinical Research Rochester, New York, United States United States, North Carolina Duke University Medical Center Durham, North Carolina, United States United States, Oregon Radiant Research Portland, Oregon, United States United States, South Carolina Radiant Research Anderson, South Carolina, United States United States, Texas Baylor University Endocrine Center Dallas, Texas, United States Dallas Diabetes and Endocrine Research Center Dallas, Texas, United States Endocrine Associates of Dallas Dallas, Texas, United States Diabetes and Grandular Disease Clinic and Reseach Center San Antonio, Texas, United States United States, Utah Endocrine Research Specialists Ogden, Utah, United States United States, Virginia Salem VA Medical Center Salem, Virginia, United States 收起 <<
NCT02638038 Multiple Sclerosis, Relapsing ... 展开 >>Remitting 收起 << Phase 2 Completed - -
NCT00631007 - Completed - -
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

1.94mL

0.39mL

0.19mL

9.72mL

1.94mL

0.97mL

19.45mL

3.89mL

1.94mL

参考文献

[1]Taygerly JP, McGee LR, et al. Discovery of INT131: a selective PPARγ modulator that enhances insulin sensitivity. Bioorg Med Chem. 2013 Feb 15;21(4):979-92.

[2]Lee DH, Huang H, et al. Selective PPARγ modulator INT131 normalizes insulin signaling defects and improves bone mass in diet-induced obese mice. Am J Physiol Endocrinol Metab. 2012 Mar 1;302(5):E552-60.